Hemab

Investment area
Novo Seeds
Date of investment
July 2021

Hemab is an emerging biotech company developing next generation therapeutics for serious, underserved bleeding and thrombosis disorders.

Hemab

Investment area
Novo Seeds
Date of investment
July 2021

Hemab is an emerging biotech company developing next generation therapeutics for serious, underserved bleeding and thrombosis disorders.

Hemab

Investment area
Novo Seeds
Date of investment
July 2021

Hemab is an emerging biotech company developing next generation therapeutics for serious, underserved bleeding and thrombosis disorders.